NCT00429806View on ClinicalTrials.gov

DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

July 31, 2007

Conditions

Vaginal Atrophy

Interventions

DRUG

DHEA

DRUG

Placebo

Trial Locations (1)

G1V 4G2

Clinique des traitements hormonaux CHUL Research Center, Québec

All Listed Sponsors

lead

CHU de Quebec-Universite Laval

OTHER

NCT00429806 - DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy | Biotech Hunter | Biotech Hunter